Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance

01 Apr 2024
Optimising Treatment in Myelofibrosis, Considerations for Ruxolitinib Resistance
At the recent MPN Expert Forum virtual symposium, Professor Claire Harrison shared her experience in managing real-world myelofibrosis and further discussed treatment options in the event of ruxolitinib failure.

Related MIMS Drugs

Editor's Recommendations